Brief: Vertex Researcher, Paul Negulescu Ph.D., Receives The 2025 Canada Gairdner International Award For Pioneering Research And Discovery Of Medicines For Cystic Fibrosis
11/04/2025 10:40
April 11 (Reuters) - Vertex Pharmaceuticals Inc VRTX.O: VERTEX RESEARCHER, PAUL NEGULESCU PH.D., RECEIVES THE 2025 CANADA GAIRDNER INTERNATIONAL AWARD FOR PIONEERING RESEARCH AND DISCOVERY OF MEDICINES FOR CYSTIC FIBROSIS Source text: ID:nBw9hyRqsa Further company coverage: VRTX.O (((( Reuters.briefs@thomsonreuters.com ;));))
Recent news on Vertex Pharmaceuticals
See all newsBrief: Vertex Announces US FDA Acceptance Of Biologics License Application For Accelerated Approval Of Povetacicept In IgA Nephropathy
U.S. RESEARCH ROUNDUP- CAVA Group, Eagle Materials, Vertiv Holdings
Vertex Q1 adjusted EPS beats estimates, revenue rises 8%
Vertex tops profit estimates as sales of new cystic fibrosis drug surge
Brief: Vertex Pharmaceuticals Q1 Adjusted EPS USD 4.47 Vs. IBES Estimate USD 4.31